loading
전일 마감가:
$1.24
열려 있는:
$1.23
하루 거래량:
56,467
Relative Volume:
0.16
시가총액:
$70.15M
수익:
$3.67M
순이익/손실:
$-13.83M
주가수익비율:
-4.4286
EPS:
-0.28
순현금흐름:
$-10.79M
1주 성능:
+8.01%
1개월 성능:
-9.46%
6개월 성능:
+105.22%
1년 성능:
-8.11%
1일 변동 폭
Value
$1.2001
$1.26
1주일 범위
Value
$1.04
$1.26
52주 변동 폭
Value
$0.48
$1.66

Icecure Medical Ltd Stock (ICCM) Company Profile

Name
명칭
Icecure Medical Ltd
Name
전화
-
Name
주소
-
Name
직원
64
Name
트위터
Name
다음 수익 날짜
2025-03-24
Name
최신 SEC 제출 서류
Name
ICCM's Discussions on Twitter

ICCM을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
ICCM
Icecure Medical Ltd
1.24 70.15M 3.67M -13.83M -10.79M -0.28
Medical Devices icon
ABT
Abbott Laboratories
131.54 225.32B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
99.99 149.74B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
376.10 142.48B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
88.56 113.49B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
71.75 42.10B 5.72B 4.17B 259.90M 6.97

Icecure Medical Ltd 주식(ICCM)의 최신 뉴스

pulisher
Mar 28, 2025

IceCure Medical Stock Dips Despite Positive ICESECRET Study Results - Zacks Investment Research

Mar 28, 2025
pulisher
Mar 28, 2025

Genomic Differences Impact Real World Use of Elacestrant in Breast Cancer - Targeted Oncology

Mar 28, 2025
pulisher
Mar 28, 2025

H.C. Wainwright maintains Buy on IceCure Medical with $2.50 target - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

IceCure Medical Ltd (NASDAQ:ICCM) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 28, 2025
pulisher
Mar 28, 2025

H.C. Wainwright maintains Buy on IceCure Medical with $2.50 target By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

IceCure Medical Reports Growth and Awaits FDA Decision - TipRanks

Mar 28, 2025
pulisher
Mar 27, 2025

IceCure Medical Ltd’s Earnings Call: Growth Amidst Challenges - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

IceCure Medical to Report 2024 Full Year Financial & Operational Results on March 27, 2025 - PR Newswire

Mar 27, 2025
pulisher
Mar 27, 2025

Earnings call transcript: Icecure Medical’s Q4 2024 sees growth in sales but wider losses By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

Earnings call transcript: Icecure Medical’s Q4 2024 sees growth in sales but wider losses - Investing.com

Mar 27, 2025
pulisher
Mar 27, 2025

IceCure Medical Reports 2024 Financial Results: 42% Growth in ProSense® Cryoablation Sales in North America - StreetInsider.com

Mar 27, 2025
pulisher
Mar 27, 2025

IceCure Reports 42% Growth: ProSense Sales Soar as FDA Breast Cancer Decision Nears - Stock Titan

Mar 27, 2025
pulisher
Mar 26, 2025

Earnings Outlook For Icecure Medical - Benzinga

Mar 26, 2025
pulisher
Mar 25, 2025

IceCure Medical aims to bring cold cancer treatment to Vietnam - Mugglehead Magazine

Mar 25, 2025
pulisher
Mar 25, 2025

Cryoablation Breast Cancer Treatment - Clinical Oncology News

Mar 25, 2025
pulisher
Mar 24, 2025

IceCure's ICESECRET Kidney Cancer Cryoablation Study Interim Results Presented at European Association of Urology Conference in Spain: 88.7% Recurrence-Free Rate - The Malaysian Reserve

Mar 24, 2025
pulisher
Mar 24, 2025

IceCure's ICESECRET Kidney Cancer Cryoablation Study Interim Res - GuruFocus

Mar 24, 2025
pulisher
Mar 24, 2025

IceCure reports high efficacy in kidney tumor cryoablation study By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

IceCure reports high efficacy in kidney tumor cryoablation study - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Breakthrough: New Kidney Cancer Study Shows 89% Success Rate with IceCure's Freezing Technology - Stock Titan

Mar 24, 2025
pulisher
Mar 21, 2025

IceCure Medical Earnings: Cryoablation Pioneer Reports 2024 Results March 27 - Stock Titan

Mar 21, 2025
pulisher
Mar 20, 2025

IceCure Reports Updated Timeline and Progress with FDA Regarding Marketing Authorization for ProSense® Cryoablation in Early-Stage Breast Cancer - The Malaysian Reserve

Mar 20, 2025
pulisher
Mar 20, 2025

Targeting ESR1 Mutations in Breast Cancer With Novel Therapies - Targeted Oncology

Mar 20, 2025
pulisher
Mar 20, 2025

IceCure stock tumbles after update on ProSense (ICCM:NASDAQ) - Seeking Alpha

Mar 20, 2025
pulisher
Mar 20, 2025

IceCure Medical Ltd. Reports Updated Timeline and Progress with FDA Regarding Marketing Authorization for ProSense®? Cryoablation in Early-Stage Breast Cancer - Marketscreener.com

Mar 20, 2025
pulisher
Mar 20, 2025

IceCure Medical Expects FDA Decision on ProSense After Q1 -March 20, 2025 at 09:20 am EDT - Marketscreener.com

Mar 20, 2025
pulisher
Mar 20, 2025

IceCure nears FDA decision on breast cancer treatment - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

IceCure nears FDA decision on breast cancer treatment By Investing.com - Investing.com UK

Mar 20, 2025
pulisher
Mar 18, 2025

IceCure's ProSense® Cryoablation Featured in Six Studies Presented at St. Gallen International Breast Cancer Conference - PR Newswire

Mar 18, 2025
pulisher
Mar 18, 2025

Breakthrough: IceCure's Breast Cancer Treatment Achieves 94% Complete Ablation Rate in New Studies - Stock Titan

Mar 18, 2025
pulisher
Mar 18, 2025

Critical Survey: IceCure Medical (NASDAQ:ICCM) and Medifocus (OTCMKTS:MDFZF) - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

IceCure secures patent for cryogenic pump in China By Investing.com - Investing.com Australia

Mar 17, 2025
pulisher
Mar 17, 2025

IceCure Receives Notice of Allowance in China for Novel Cryogenic Pump for Next-Generation Cryoablation Technology - Quantisnow

Mar 17, 2025
pulisher
Mar 17, 2025

IceCure Gets Notice of Allowance from China's Intellectual Property Regulator -March 17, 2025 at 09:07 am EDT - MarketScreener

Mar 17, 2025
pulisher
Mar 17, 2025

IceCure secures patent for cryogenic pump in China - Investing.com

Mar 17, 2025
pulisher
Mar 17, 2025

Market Sentiment Around Loss-Making IceCure Medical Ltd (NASDAQ:ICCM) - Simply Wall St

Mar 17, 2025
pulisher
Mar 15, 2025

IceCure's ProSense® Cryoablation Featured in Six Studies Present - GuruFocus.com

Mar 15, 2025
pulisher
Mar 14, 2025

Breast Cancer Patients Report Higher Satisfaction with Cryoablation - Imaging Technology News

Mar 14, 2025
pulisher
Mar 11, 2025

IceCure Medical (NASDAQ:ICCM) Trading Down 4.4% – Time to Sell? - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Clinical Study: ProSense Shows Superior Patient Satisfaction vs Traditional Breast Cancer Therapy - StockTitan

Mar 10, 2025
pulisher
Mar 10, 2025

Breast Cancer Patients who Underwent IceCure's ProSense® Cryoablation in Japan Reported Significantly Higher Satisfaction than Patients who Underwent Standard of Care Surgery - The Malaysian Reserve

Mar 10, 2025
pulisher
Feb 26, 2025

IceCure Medical (ICCM) Moves to Buy: Rationale Behind the Upgrade - MSN

Feb 26, 2025
pulisher
Feb 25, 2025

IceCure seeks Israeli regulatory approval for XSense cryoablation system - Yahoo

Feb 25, 2025
pulisher
Feb 24, 2025

IceCure seeks Israel approval for XSense cryoablation system By Investing.com - Investing.com Australia

Feb 24, 2025
pulisher
Feb 24, 2025

IceCure Medical Ltd. Submits Filing for Regulatory Approval of Its Next-Generation XSense? Cryoablation System in Israel - Marketscreener.com

Feb 24, 2025
pulisher
Feb 24, 2025

IceCure seeks Israel approval for XSense cryoablation system - Investing.com

Feb 24, 2025
pulisher
Feb 24, 2025

IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense™ Cryoablation System in Israel - PR Newswire

Feb 24, 2025

Icecure Medical Ltd (ICCM) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
medical_devices STE
$227.12
price up icon 0.69%
medical_devices ZBH
$112.20
price down icon 0.15%
medical_devices PHG
$24.82
price down icon 1.68%
$67.68
price up icon 0.74%
$79.18
price down icon 0.49%
medical_devices EW
$71.74
price down icon 0.19%
자본화:     |  볼륨(24시간):